| Literature DB >> 19558708 |
Dinesh Pradhan1, Nandita Kakkar, Amanjit Bal, Shrawan Kumar Singh, Kusum Joshi.
Abstract
BACKGROUND: Adult renal epithelial neoplasms are a heterogeneous group with varying prognosis and outcome requiring sub-classification.Entities:
Year: 2009 PMID: 19558708 PMCID: PMC2714064 DOI: 10.1186/1746-1596-4-21
Source DB: PubMed Journal: Diagn Pathol ISSN: 1746-1596 Impact factor: 2.644
Detailed Description of Discordant Cases (N = 28)
| 1 | CCRCC vs papillary | - | - | - | Papillary RCC | ||
| 2 | CCRCC vs Chromophobe | - | + | - | - | Conventional RCC | |
| 3 | Papillary RCC vs CCRCC | - | - | - | Conventional RCC | ||
| 4 | Chromophobe RCC vs CCRCC | + | + | 3+, m | - | PNV | Chromophobe RCC |
| 5 | Papillary RCC vs CCRCC | 3+ | + | - | Papillary RCC | ||
| 6 | Collecting duct RCC vs Papillary | 2+ | 3+ | - | Papillary RCC | ||
| 7 | CCRCC vs papillary | + | 2+ | - | Papillary RCC | ||
| 8 | ACC vs CCRCC | 3+ | - | - | Conventional RCC | ||
| 9 | Chromophobe RCC vs CRCC | + | - | 2+, m | - | Chromophobe RCC | |
| 10 | CCRCC vs Papillary | + | - | - | Conventional RCC | ||
| 11 | Collecting duct RCC vs CCRCC | 2+ | 2+ | 2+ | Collecting duct RCC | ||
| 12 | CCRCC vs oncocytoma | - | - | - | Conventional RCC | ||
| 13 | Chromophobe vs CCRCC | - | + | - | - | Conventional RCC | |
| 14 | Chromophobe vs CCRCC | + | - | 2+, m | - | PNV | Chromophobe RCC |
| 15 | Chromophobe vs CCRCC | - | - | - | - | Conventional RCC | |
| 16 | CCRCC vs papillary | - | + | - | Papillary RCC | ||
| 17 | CCRCC vs Sarcomatoid | - | - | - | Sarcomatoid RCC | ||
| 18 | Papillary RCC vs CCRCC | + | 2+ | - | Papillary RCC | ||
| 19 | Chromophobe vs CCRCC | + | - | 2+, m | - | Chromophobe RCC | |
| 20 | Chromophobe RCC vs CCRCC | - | - | - | - | Glycogen | Conventional RCC |
| 21 | Chromophobe vs CCRCC | - | 2+ | - | - | Conventional RCC | |
| 22 | CCRCC vs chromophobe | - | 3+ | 3+ | - | Papillary RCC | |
| 23 | Chromophobe vs oncocytoma | - | 3+ | - | PNV | Chromophobe RCC | |
| 24 | CC RCC vs papillary | 2+ | 3+ | - | No PNV | Papillary RCC | |
| 25 | Chromophobe vs CCRCC | + | 2+ | + | - | Chromophobe RCC | |
| 26 | CCRCC vs Chromophobe | + | - | 3+, m | - | Chromophobe RCC | |
| 27 | CCRCC vs papillary | - | - | - | Conventional RCC | ||
| 28 | Oncocytoma vs ACC vs CCRCC | - | - | - | Conventional RCC |
CCRCC – Conventinal/clear cell RCC, ACC – adrenocortical carcinoma, m – membranous accentuation, PNV-Perinuclear vesicles
Sub-types of Renal Cell Carcinomas amongst total cases (N = 278)
| 197(78.8) | 208(74.8) | |
| 26(10.4) | 34(12.2) | |
| 15(6) | 22(7.9) | |
| 5(2) | 5(1.8) | |
| 0(0) | 1 (0.4) | |
| 7(2.8) | 8(2.9) |
Figure 1Photomicrograph of Hale's colloidal iron stain showing deep blue granular cytoplasmic positivity in chromophobe RCC (HCI with hematoxylin counterstain, ×200).
Figure 2Bar diagram showing CK7 positivity in RCC(CCRCC-Clear cell renal cell carcinoma; PRCC-Papillary renal cell carcinoma; CRCC-Chromophobe renal cell carcinoma; CDC-Collecting duct carcinoma; RO-Renal Oncocytoma).
Figure 3Immunohistochemical staining using CK7 antibody showing strong and diffuse membranous positivity in chromophobe renal cell carcinoma(A) and collecting duct carcinoma(B) (CK7, ×200).
Figure 4Photomicrograph showing weak but distinct vinculin positivity on the cell membrane of chromophobe RCC(Vinculin, ×200).
Figure 5Electron microscopy showing numerous mitochondria packing the cytoplasm in oncocytoma (Uranyl acetate and lead citrate, × 10,000).
Comparison of incidence of Sub-types of Renal Cell Carcinomas with Western and Asian studies
| 208 (74.8%) | 34(12.2%) | 22(7.9%) | 5(1.8%) | 1(0.5%) | - | |
| 114 (64.0%) | 48 (27.0%) | 14 (7.86%) | - | 2 (1.12%) | - | |
| 77(67.5%) | 11(9.6%) | 14(12.3%) | - | - | 2(1.8%) | |
| 3564(87.7%) | 396(9.7%) | 103(2.5%) | - | - | - | |
| 686(86.3%) | 58(7.3%) | 49(6.16%) | - | 2(0.25%) | - | |
| 558(88.7%) | 53(8.4%) | 13(2.1%) | - | - | - | |
| 80% | 10% | 5% | 5% | - | - | |
| 255(63%) | 75(18.5%) | 24(5.9%) | - | - | 23(5.7%) |